RNA Nanotherapeutics receives NCI STTR grant to develop new breast cancer treatment
Venture Lab-backed startup uses RNA nanoparticles in a targeted approach
Grant and Award Announcement
Grant renewal bolsters University of Cincinnati breast cancer research
UC Researcher Receives Patent
RNA nanoparticle hoped to overcome drug resistance, increase efficacy and lower treatment toxicity
A New Co-Driver in Breast Cancer
UC researchers discover ‘gene cooperation’ in cancer growth and can target treatments to stop it
Pink: A Color for Fighters
In October, we wear pink, but everyday, UC fights cancer
R01 Grant Funds Research on Small RNAs
R01 grant funds research examining small RNAs in metastatic breast cancer
UC Professor Makes New Breast Cancer Discovery
Nearly one in eight women will be diagnosed with breast cancer during their lifetime.
UC Researchers Find a Key Breast Cancer Protein
UC Researchers Find Protein That Mediates Formation of HER2 Breast Cancer
Thousands to Walk in Solidarity to Raise Awareness
Zhang, an American Cancer Society research scholar, is one of this year’s Cincinnati area’s Real Men Wear Pink participants.
COM Faculty Among Accelerator Award Winners
Three College of Medicine faculty are among the recipients of awards by the UC Technology Accelerator for Commercialization.
Beating Therapy-Resistant Breast Cancer with RNA Nanoparticles
Scientists at the University of Cincinnati (UC) College of Medicine say they have been able to generate multifunctional RNA nanoparticles that could overcome treatment resistance in breast cancer.
IndyCar Driver Makes Pit Stop at UC Cancer Institute
IndyCar driver Pippa Mann visited with researchers and clinicians at University of Cincinnati Cancer Institute.
New Clues for Overcoming Tamoxifen-Resistant Breast Cancer
A University of Cincinnati (UC) cancer biology team reports breakthrough findings about specific cellular mechanisms that may help overcome endocrine (hormone) therapy-resistance in breast cancer patients.